PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 15 filers reported holding PDL BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,010,000 | +1.0% | 1,000,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000,000 | -4.3% | 1,000,000 | 0.0% | 0.00% | – |
| Q4 2019 | $1,045,000 | +12.2% | 1,000,000 | 0.0% | 0.00% | – |
| Q3 2019 | $931,000 | -75.6% | 1,000,000 | -72.2% | 0.00% | -100.0% |
| Q2 2019 | $3,823,000 | +6.2% | 3,594,000 | +17.4% | 0.00% | 0.0% |
| Q1 2019 | $3,599,000 | +3.3% | 3,062,000 | -9.9% | 0.00% | 0.0% |
| Q4 2018 | $3,483,000 | +17.0% | 3,399,000 | +11.3% | 0.00% | 0.0% |
| Q3 2018 | $2,978,000 | -18.0% | 3,054,000 | -23.9% | 0.00% | 0.0% |
| Q2 2018 | $3,632,000 | +33.0% | 4,013,000 | +49.2% | 0.00% | 0.0% |
| Q1 2018 | $2,730,000 | +4.0% | 2,689,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,624,000 | +95.1% | 2,689,000 | +117.4% | 0.00% | – |
| Q3 2017 | $1,345,000 | +274.7% | 1,237,000 | +209.2% | 0.00% | – |
| Q2 2017 | $359,000 | – | 400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 8,575,000 | $7,002,000 | 7.67% |
| Man Investments (CH) AG | 4,500,000 | $3,645,000 | 2.12% |
| Park West Asset Management LLC | 22,250,000 | $17,870,000 | 1.38% |
| Telemetry Investments, L.L.C. | 3,000,000 | $2,409,000 | 1.36% |
| WHITEBOX ADVISORS LLC | 27,961,000 | $22,456,000 | 0.89% |
| Kissinger Financial Services LLC | 2,652,000 | $2,127,000 | 0.74% |
| ZAZOVE ASSOCIATES LLC | 9,560,000 | $7,839,000 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,700,000 | $13,528,000 | 0.18% |
| LINDEN ADVISORS LP | 4,000,000 | $3,253,000 | 0.13% |
| AQR Arbitrage LLC | 5,000,000 | $4,041,000 | 0.04% |